Brexit and Community Pharmacy – PSNC Website

The United Kingdom left the European Union (EU) on Friday January 31, 2020, with a transition period in place until December 31, 2020. Now, as the GOV.UK website states, new rules apply to things like travel and business with Europe.

The common goal of government and actors in the medicines supply chain is to ensure continuity of supply of medicines to pharmacies and their patients after the UK leaves the EU. The PSNC will continue to represent the interests of community pharmacies in discussions on this topic under the Department of Health and Social Care’s (DHSC) EU Exit Medicines Supply Industry Collaborative Group ). We also work closely with other national pharmaceutical organizations through our Community Pharmacy Brexit Forum.

Community pharmacy, the UK-EU trade deal and the end of the transition period

In preparation for leaving the EU (before the start of the transition period), the DHSC has developed a multi-layered approach to protect the supply of medicines and medical goods. These measures have been reviewed for the end of the transition period and adapted if necessary.

On 30 December 2020, Minister for Health Edward Argar MP wrote to his health and social care colleagues to provide an update on the UK-EU Trade and Cooperation Agreement. The letter includes information on continuity of drug supply, reciprocal health care, health safety and science, data and professional qualifications, and the Minister thanks everyone working in the sector for their dedication to the unprecedented challenges of 2020.

The letter can be read in full hereor you can read PSNC’s summary here.

Older updates

DHSC Letter to Suppliers of Drugs and Medical Products (August 3, 2020)
This letter from Steve Oldfield, Chief Commercial Officer, sets out the Government’s plan and demands from industry and the wider supply chain before the end of the transition period to help ensure continuity of supply of medical products to and from the UK. You can also view a summarized version of this information in PSNC news.

DHSC Letter to Suppliers of Drugs and Medical Products (November 17, 2020)
This letter updates the August 2020 letter.

Exiting the EU – continuity of drug supply: NHSE&I letter from Dr Keith Ridge (December 10, 2020)
This letter from Keith Ridge, Chief Pharmaceutical Officer for England, explains the work that has been undertaken to ensure continuity of drug supply until the end of the transition period. He advises NHS organizations not to store locally and not to change prescribing behaviors.

Exiting the EU: Supply of medicines in primary care (December 17, 2020)
The PSNC and the British Medical Association (BMA) have issued this joint statement on the supply of medicines before the end of the Brexit transition period, indicating the united position in primary care. It acknowledges the significant amount of work undertaken by DHSC and NHSE&I, and underlines the importance of working collaboratively to maintain patient care.

Related Information

Severe Shortage Protocols (SSP) Live

Comments are closed.